Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery

March 29, 2026 updated by: Keuro MedTech

Evaluation of Clinical Effectiveness and Safety of Tarvos Microguidewire in Neurovascular Interventional Surgery

This investigation is to evaluate the clinical effectiveness and safety of the Tarvos Microguidewire in the neurovascular interventional surgery. It is a retrospective multicenter medical device clinical study with real-world data.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

121

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
      • Xingtai, China
        • Xingtai central hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Undertaken a neurovascular surgery procedure including Tarvos Microguidewire

Description

Inclusion Criteria:

  • Undertaken a neurovascular surgery procedure including Tarvos microguidewire
  • Available images of Tarvos Microguidewire in the neurovascular surgery.

Exclusion Criteria:

  • Disorders of vascular fragility (e.g. Ehlers-Danlos syndrome)
  • Prior vascular dissection or injury to the target vessels
  • Not meeting the data requirements needed for this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
single arm
Device: Tarvos Microguidewire
This product is indicated for use in neurovascular interventions to assist in the delivery of diagnostic or therapeutic devices to the target lesion site.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Device success rate
Time Frame: during surgery
Number of patients with device success / Number of recruited patients* 100%
during surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
Ability to assist in the delivery of other interventional devices to the targeted vessel position.
Time Frame: during surgery
during surgery

Other Outcome Measures

Outcome Measure
Time Frame
Incidence of adverse events, serious adverse events and device deficiencies
Time Frame: within postoperative 24 hrs
within postoperative 24 hrs

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Keuro MedTech

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 29, 2026

Primary Completion (Actual)

March 15, 2026

Study Completion (Actual)

March 15, 2026

Study Registration Dates

First Submitted

March 24, 2026

First Submitted That Met QC Criteria

March 24, 2026

First Posted (Actual)

March 30, 2026

Study Record Updates

Last Update Posted (Actual)

April 2, 2026

Last Update Submitted That Met QC Criteria

March 29, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CIP-Reachx-RWD

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Ischemic Stroke

Clinical Trials on Tarvos Microguidewire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe